Skip to main content
. Author manuscript; available in PMC: 2019 Jun 20.
Published in final edited form as: ACS Chem Neurosci. 2018 Apr 6;9(6):1327–1337. doi: 10.1021/acschemneuro.7b00510

Figure 7. MDPV-induced hyperactivity is not significantly affected by L-SPD.

Figure 7.

Data were measured as counts and summed over 90 min. L-SPD pretreatment (10 mg/kg) by itself had no effects on either ambulatory activity (a) or stereotypy (b) (both p > 0.05). MDPV (2 mg/kg) treatment significantly increased ambulation (a) and stereotypy (b) (both p < 0.001), neither of which were affected by pretreatment with L-SPD (10 mg/kg) (both p > 0.05). Data are shown as mean + S.E.M. (n = 7–8 per group). VEH, vehicle; SAL, saline.